Compare, Analyse ASTRAZENECA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TEVA PHARMA
Dec-13
ASTRAZENECA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2783,062-   
Low Rs8832,660-   
Sales per share (Unadj.) Rs228.41,757.4-  
Earnings per share (Unadj.) Rs10.4109.8-  
Cash flow per share (Unadj.) Rs16.3251.8-  
Dividends per share (Unadj.) Rs096.10-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs98.81,952.1-  
Shares outstanding (eoy) m25.00848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.71.6 290.5%   
Avg P/E ratio x104.226.1 400.0%  
P/CF ratio (eoy) x66.411.4 584.8%  
Price / Book Value ratio x10.91.5 746.3%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m27,0082,426,162 1.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.933,156.9 12.7%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.12,071.3 9.2%   
INCOME DATA
Net Sales Rs m5,7101,490,235 0.4%  
Other income Rs m1230-   
Total revenues Rs m5,8331,490,235 0.4%   
Gross profit Rs m463408,102 0.1%  
Depreciation Rs m147120,457 0.1%   
Interest Rs m029,271 0.0%   
Profit before tax Rs m438258,374 0.2%   
Minority Interest Rs m01,174 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-169,608 0.0%   
Tax Rs m179-3,154 -5.7%   
Profit after tax Rs m25993,094 0.3%  
Gross profit margin %8.127.4 29.6%  
Effective tax rate %40.8-1.2 -3,345.5%   
Net profit margin %4.56.2 72.6%  
BALANCE SHEET DATA
Current assets Rs m3,2091,006,499 0.3%   
Current liabilities Rs m2,070877,752 0.2%   
Net working cap to sales %20.08.6 231.0%  
Current ratio x1.61.1 135.2%  
Inventory Days Days7291 79.7%  
Debtors Days Days3596 36.4%  
Net fixed assets Rs m790486,744 0.2%   
Share capital Rs m503,668 1.4%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,4691,655,368 0.1%   
Long term debt Rs m0761,990 0.0%   
Total assets Rs m4,6053,405,665 0.1%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 283.3%   
Return on assets %5.63.6 156.6%  
Return on equity %10.55.6 186.6%  
Return on capital %17.74.9 359.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88237,466 0.0%  
From Investments Rs m-94-84,144 0.1%  
From Financial Activity Rs mNA-284,857 0.0%  
Net Cashflow Rs m-6-131,534 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.36 Rs / USD

Compare ASTRAZENECA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ASTRAZENECA PHARMA With: FRESENIUS KABI ONCO.  ALKEM LABORATORIES  SUVEN LIFE SCIENCES  BIOCON   FULFORD INDIA  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; Adani Ports and Tata Steel Among Top Nifty Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended lower.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ASTRAZENECA PHARMA SHARE PRICE


Jun 16, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS